Pre-clinical clinical evaluation of TE/RM products
Abstract
There is an established pathway for pharmaceutical compound development and review by the FDA. Developers of TE/RM products have to improvise certain parts of this established pathway, especially regarding ADME Tox testing. Both in vitro and in vivo animal testing is required before the FDA will allow any medicinal product to be tested in humans. These studies need to be well defined, controlled and monitored. Development and execution of a clinical trial rely heavily on the experience of the clinical investigator, who works in close collaboration with the study sponsor. For small companies who may not have the depth of experience required to monitor the study within their own employees, ...
Get Developments in Tissue Engineered and Regenerative Medicine Products now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
